- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 11 residues within 4Å:- Chain A: S.62, V.64, R.325, A.406, W.407
- Chain B: W.405, F.420, H.421, Q.422, E.423
- Ligands: HEM.1
10 PLIP interactions:9 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.325, A:R.325, A:A.406, A:W.407
- Water bridges: A:G.61, A:L.63
- pi-Stacking: A:W.407, A:W.407
- pi-Cation interactions: A:W.407
- Hydrophobic interactions: B:E.423
H4B.13: 12 residues within 4Å:- Chain A: W.405, F.420, H.421, Q.422, E.423
- Chain B: S.62, V.64, R.325, A.406, W.407
- Ligands: HEM.12, GOL.18
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.325, B:R.325, B:A.406, B:W.407
- pi-Stacking: B:W.407, B:W.407
- Hydrophobic interactions: A:E.423
- Water bridges: A:H.421
- 2 x XVF: 6-(2-{5-[2-(diethylamino)ethyl]-2,3-difluorophenyl}ethyl)-4-methylpyridin-2-amine(Non-covalent)
XVF.3: 14 residues within 4Å:- Chain A: V.64, F.65, P.294, V.296, M.299, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, Y.435
- Ligands: HEM.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:V.64, A:F.65, A:P.294, A:F.313, A:Y.435
- Hydrogen bonds: A:M.318, A:E.321
XVF.14: 15 residues within 4Å:- Chain B: V.64, F.65, P.294, V.296, M.299, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, W.407, Y.435
- Ligands: HEM.12
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:V.64, B:P.294, B:P.294, B:F.313, B:W.407, B:Y.435
- Hydrogen bonds: B:M.318, B:E.321
- 5 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
BTB.4: 5 residues within 4Å:- Chain A: W.282, V.341, C.342, D.344
- Ligands: GD.10
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:D.344
BTB.5: 3 residues within 4Å:- Chain A: E.337, T.347, R.348
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.337, A:T.347, A:T.347
- Salt bridges: A:E.337
BTB.6: 3 residues within 4Å:- Chain A: D.257, E.258, P.259
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:E.258
BTB.15: 3 residues within 4Å:- Chain B: T.279, E.281
- Ligands: GD.22
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.281, B:E.281
- Water bridges: B:T.279
- Salt bridges: B:E.281
BTB.16: 2 residues within 4Å:- Chain B: D.257, E.258
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:E.258
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 1 residues within 4Å:- Chain A: E.127
No protein-ligand interaction detected (PLIP)GOL.8: 1 residues within 4Å:- Chain A: Q.217
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.217
GOL.17: 5 residues within 4Å:- Chain B: V.131, K.135, L.153, Q.154, V.155
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.135, B:V.155
GOL.18: 5 residues within 4Å:- Chain B: V.64, R.325, H.331, W.407
- Ligands: H4B.13
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.325, B:H.331
- Water bridges: B:D.329, A:H.421
GOL.19: 1 residues within 4Å:- Chain B: D.338
1 PLIP interactions:1 interactions with chain B- Water bridges: B:D.338
GOL.20: 1 residues within 4Å:- Chain B: E.337
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.337
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x GD: GADOLINIUM ATOM(Non-functional Binders)(Non-covalent)
GD.10: 1 residues within 4Å:- Ligands: BTB.4
No protein-ligand interaction detected (PLIP)GD.22: 3 residues within 4Å:- Chain B: T.279, E.281
- Ligands: BTB.15
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.279, B:E.281, H2O.14
GD.23: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vasu, D. et al., Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-10-11
- Peptides
- Nitric oxide synthase, endothelial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 8fgs.1 (1 other biounit)
Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(5-(2-(diethylamino)ethyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine
Nitric oxide synthase, endothelial
Related Entries With Identical Sequence
4d1o.1 | 4d1p.1 | 5uo8.1 | 5uo8.2 | 5uo9.1 | 5uo9.2 | 5uoa.1 | 5uob.1 | 5uob.2 | 5uoc.1 | 5uoc.2 | 5vvb.1 | 5vvb.2 | 5vvc.1 | 5vvc.2 | 5vvd.1 | 5vvd.2 | 6av6.1 | 6av6.2 | 6av7.1 | 6av7.2 | 6cie.1 | 6cie.2 | 6cif.1 | 6cif.2 | 6nh1.1 | 6nh1.2 | 6nh2.1 | 6nh2.2 | 6nh3.1 more...less...6nh3.2 | 6nh4.1 | 6nh4.2 | 6nh5.1 | 6nh5.2 | 6nh6.1 | 6nh6.2 | 6nh7.1 | 6nh8.1 | 6nh8.2 | 6nhf.1 | 6nhf.2 | 6pou.1 | 6pou.2 | 6pou.3 | 6pov.1 | 6pov.2 | 6pow.1 | 6pow.2 | 6pox.1 | 6pox.2 | 6poy.1 | 6poy.2 | 6poz.1 | 6poz.2 | 6pp0.1 | 6pp0.2 | 6pp1.1 | 6pp1.2 | 6pp2.1 | 6pp2.2 | 6pp3.1 | 6pp3.2 | 6pp4.1 | 6pp4.2 | 7m56.1 | 7tsg.1 | 7tsg.2 | 7tsh.1 | 7tsh.2 | 7tsi.1 | 7tsi.2 | 7tsk.1 | 7tsk.2 | 7tsl.1 | 7tsl.2 | 7tsm.1 | 7tsm.2 | 7tsn.1 | 7tsn.2 | 7tso.1 | 7tso.2 | 7tsp.1 | 7tsp.2 | 7uao.1 | 7uao.2 | 8fgn.1 | 8fgn.2 | 8fgo.1 | 8fgo.2 | 8fgp.1 | 8fgp.2 | 8fgq.1 | 8fgq.2 | 8fgr.1 | 8fgr.2 | 8fgs.2 | 8fgt.1 | 8fgt.2 | 8fgu.1 | 8fgu.2 | 8ufr.1 | 8ufr.2 | 8ufu.1 | 8ufu.2